Sandip Kapadia, Chief Financial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 354 shares at $58.83 ($21K) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Open-market sale of $21k ICPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| HRMY | SELL | 2025-12-09 | $791K | — | Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |